Archive
Events Search and Views Navigation
July 2022
The Next Frontier in Immunotherapy for Multiple Myeloma: What Will BCMA Targeting Mean for Our Relapsed/Refractory Patients? Video Activity
Key learning objectives:
∙ Explain the mechanism of action of BCMA-targeted strategies for the treatment of relapsed/refractory multiple myeloma (RRMM)
∙ Evaluate the clinical evidence with BCMA-targeted approaches for the treatment of RRMM
∙ Discuss practical considerations, including key differences between BCMA-targeted treatments, that may inform their use in RRMM
September 2022
Use of PDL-1 Inhibitors in a Lymphoma Population
At the end of the session participants will be able to:
- describe the mechanism of action of PD-L1 inhibitors
- identify the indications for use of PD-L1 inhibitors in lymphoma
- list PD-L1 specific toxicities
Accreditation:
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by the Canadian Association of Pathologists. You may claim a maximum of 1 hour per event attended. (credits are automatically calculated).
Target Audience: Hematologists Medical Oncologists, Residents
CanMEDS: Medical Expert (the integrating roles), Scholar
Declaration of Conflict of Interest: Novartis - research funding, BMS - speaking honoraria
Find out more »October 2022
Covid-19 and Thrombosis – HOLD THE DATE, October 5, 2022
Dr. Lana Castellucci, MD, FRCPC, MSc
Scientist, Clinical Epidemiology Program, Ottawa Hospital Research Institute
Associate Professor, University of Ottawa, Faculty of Medicine, Department of Medicine
Division of Hematology and General Internal Medicine, The Ottawa Hospital
November 2022
3rd Regional Symposium on Myelodysplastic Syndromes (MDSR 2022) – Kyoto, Japan
MDS is the premier forum for presenting the most recent advancements in Myelodysplastic Syndromes and offers you the opportunity to learn from world-renowned hematology and oncology experts, establish strong, professional relationships with international colleagues, form collaborations and grow in your career.
The 2022 Regional Symposium will cover the latest science on basic, translational and clinical aspects of MDS diagnosis, prognosis, and treatment. The meeting will also feature abstract presentations on novel research discoveries that can greatly improve the way we see and treat patients with MDS.
Be part of the advancement of MDS science and patient care by joining the global community at MDSR 2022 on 4 - 5 November 2022 in Kyoto, Japan.
December 2022
CHS Awards Gala – December 11, 2022
CHS Members are invited to attend a reception to honour achievements and be provided with a CHS update
Find out more »